Swiss National Bank Soma Logic, Inc. Transaction History

Swiss National Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$1.76 - $2.83 $55,792 - $89,711	-31,700 Reduced 9.12%	316,000 $799,000
Q2 2023 Aug 09, 2023	BUY	$2.1 - $3.36 $92,820 - $148,512	44,200 Added 14.56%	347,700 $803,000
Q1 2023 May 10, 2023	SELL	$2.13 - $3.6 $61,131 - $103,320	-28,700 Reduced 8.64%	303,500 $773,000
Q4 2022 Feb 08, 2023	BUY	$2.05 - $3.47 $21,524 - $36,435	10,500 Added 3.26%	332,200 $833,000
Q2 2022 Aug 09, 2022	BUY	$4.27 - $8.26 $1.37 Million - $2.66 Million	321,700 New	321,700 $1.45 Million

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.